Guorui (Grace) Xie
About Guorui (Grace) Xie
Guorui (Grace) Xie is a Scientist I in Discovery Biology at RAPT Therapeutics, with over 13 years of research experience in immunology, oncology, and virology. She holds a certification in Clinical Research and has contributed to numerous peer-reviewed articles and presented at various scientific conferences.
Work at Rapt Therapeutics
Guorui (Grace) Xie serves as Scientist I in Discovery Biology at RAPT Therapeutics, a position she has held since 2021. Located in South San Francisco, California, RAPT Therapeutics focuses on developing innovative therapies for cancer and inflammatory diseases. In her role, Xie applies her extensive research background to contribute to the discovery and development of new treatments.
Education and Expertise
Xie has a diverse educational background. She studied at Shandong Normal University from 2003 to 2007. She then pursued her PhD at The University of Texas Medical Branch at Galveston, focusing on immune responses to West Nile virus infection from 2009 to 2015. Additionally, she completed a Certificate Program in Clinical Research Conduct and Management at UC Berkeley Extension in 2017. Xie possesses advanced technical skills, including expertise in 10X Genomics single cell sequencing and digital droplet PCR.
Research Experience
With over 13 years of experience, Xie has worked extensively in the fields of inflammatory disease, cancer immunotherapy, and drug discovery. She has six years of research experience specifically in the study of West Nile Virus and the immunology and HIV fields. Additionally, she has two years of experience in oncology research, contributing to her comprehensive understanding of various biological systems.
Publications and Presentations
Xie has made significant contributions to the scientific community, authoring 30 peer-reviewed articles across the fields of immunology, oncology, and virology. She has also presented eight abstracts at national and international scientific conferences, showcasing her research findings and engaging with the broader scientific community.